Stocks and Investing Stocks and Investing
Tue, November 9, 2021

Andrew Galler Initiated (ADCT) at Buy and Held Target at $44 on, Nov 9th, 2021


Published on 2024-10-27 18:34:41 - WOPRAI, Andrew Galler
  Print publication without navigation


Andrew Galler of Wolfe Research, Initiated "ADC Therapeutics SA" (ADCT) at Buy and Held Target at $44 on, Nov 9th, 2021.

Andrew has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Kennen MacKay of "RBC Capital" Maintained at Buy with Increased Target to $34 on, Wednesday, November 3rd, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $47 on, Tuesday, September 7th, 2021
Contributing Sources